Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 5
2015 3
2016 6
2017 6
2018 5
2019 4
2020 5
2021 4
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
High Prevalence of Abacavir-associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy.
Dziuban EJ, DeVos J, Ngeno B, Ngugi E, Zhang G, Sabatier J, Wagar N, Diallo K, Nganga L, Katana A, Yang C, Rivadeneira ED, Mukui I, Odhiambo F, Redfield R, Raizes E. Dziuban EJ, et al. Among authors: mukui i. Pediatr Infect Dis J. 2017 Aug;36(8):758-760. doi: 10.1097/INF.0000000000001597. Pediatr Infect Dis J. 2017. PMID: 28383390 Free PMC article.
Advancing the prevention and treatment of HIV in children: priorities for research and development.
Penazzato M, Townsend CL, Sam-Agudu NA, Ruel TD, Archary M, Bekker A, Cressey TR, Colbers A, Sugandhi N, Rojo P, Rakhmanina N, Watkins M, Frigati L, Mukui I, Hafiz A, Vicari M, Capparelli EV, Abrams EJ; PADO-HIV 5 participants. Penazzato M, et al. Among authors: mukui i. Lancet HIV. 2022 Sep;9(9):e658-e666. doi: 10.1016/S2352-3018(22)00101-1. Epub 2022 Jul 18. Lancet HIV. 2022. PMID: 35863362 Review.
"After viral load testing, I get my results so I get to know which path my life is taking me": qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies.
Qian SRW, Hassan SA, Scallon AJ, Oyaro P, Brown E, Wagude J, Mukui I, Kinywa E, Oluoch F, Odhiambo F, Oyaro B, Kingwara L, Yongo N, Karauki E, Gao J, Otieno L, John-Stewart GC, Abuogi LL, Patel RC. Qian SRW, et al. Among authors: mukui i. BMC Health Serv Res. 2022 Dec 17;22(1):1540. doi: 10.1186/s12913-022-08593-z. BMC Health Serv Res. 2022. PMID: 36528677 Free PMC article.
Pediatric Treatment Scale-Up: The Unfinished Agenda of the Global Plan.
Penazzato M, Amzel A, Abrams EJ, Kiragu K, Essajee S, Mukui I, Elyanu P, Rwebembera AA, Mbori-Ngacha D. Penazzato M, et al. Among authors: mukui i. J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S59-S65. doi: 10.1097/QAI.0000000000001333. J Acquir Immune Defic Syndr. 2017. PMID: 28398998 Review.
"I feel drug resistance testing allowed us to make an informed decision": qualitative insights on the role of HIV drug resistance mutation testing among children and pregnant women living with HIV in western Kenya.
Scallon AJ, Hassan SA, Qian SR, Gao Y, Oyaro P, Brown E, Wagude J, Mukui I, Kinywa E, Oluoch F, Odhiambo F, Oyaro B, Kingwara L, Yongo N, Karauki E, Otieno L, John-Stewart GC, Abuogi LL, Patel RC. Scallon AJ, et al. Among authors: mukui i. BMC Health Serv Res. 2023 Aug 24;23(1):908. doi: 10.1186/s12913-023-09804-x. BMC Health Serv Res. 2023. PMID: 37620855 Free PMC article. Clinical Trial.
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies.
Jacobs TG, Schouwenburg S, Penazzato M, Archary M, Ruel TD, van den Anker J, Burger DM, Cressey TR, Abrams EJ, Lyall H, Bekker A, Colbers A; Penta Clinical Pharmacology Working Group; PADO-HIV 5 participants. Jacobs TG, et al. Lancet HIV. 2022 Sep;9(9):e649-e657. doi: 10.1016/S2352-3018(22)00121-7. Epub 2022 Jul 18. Lancet HIV. 2022. PMID: 35863363 Review.
'I saw it as a second chance': A qualitative exploration of experiences of treatment failure and regimen change among people living with HIV on second- and third-line antiretroviral therapy in Kenya, Malawi and Mozambique.
Burns R, Borges J, Blasco P, Vandenbulcke A, Mukui I, Magalasi D, Molfino L, Manuel R, Schramm B, Wringe A. Burns R, et al. Among authors: mukui i. Glob Public Health. 2019 Aug;14(8):1112-1124. doi: 10.1080/17441692.2018.1561921. Epub 2019 Jan 11. Glob Public Health. 2019. PMID: 30632883
Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV.
Ruel T, Penazzato M, Zech JM, Archary M, Cressey TR, Goga A, Harwell J, Landovitz RJ, Lain MG, Lallemant M, Namusoke-Magongo E, Mukui I, Permar SR, Prendergast AJ, Shapiro R, Abrams EJ. Ruel T, et al. Among authors: mukui i. Glob Health Sci Pract. 2023 Apr 28;11(2):e2200401. doi: 10.9745/GHSP-D-22-00401. Print 2023 Apr 28. Glob Health Sci Pract. 2023. PMID: 37116934 Free PMC article.
Casting a Wide Net: HIV Drug Resistance Monitoring in Pre-Exposure Prophylaxis Seroconverters in the Global Evaluation of Microbicide Sensitivity Project.
Levy L, Peterson JM, Kudrick LD, Chohan B, Bosek E, Mukui I, Mugambi M, Masyuko S, Mugurungi O, Ndlovu N, Mahaka I, Dunbar M, Hettema A, Kuwengwa RAP, Matse S, Mullick S, Greener L, O'Connor C, Pillay D, Fawzy M, Mellors JW, Parikh UM; Global Evaluation of Microbicide Sensitivity (GEMS) project. Levy L, et al. Among authors: mukui i. Glob Health Sci Pract. 2022 Apr 29;10(2):e2100122. doi: 10.9745/GHSP-D-21-00122. Print 2022 Apr 28. Glob Health Sci Pract. 2022. PMID: 35487541 Free PMC article.
47 results